A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

Recursion Pharmaceuticals ( RXRX 3.12%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Windows chief Pavan Davuluri says the OS is “evolving into an agentic platform,” sparking major backlash online.

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...

After a year of boardroom declarations about “AI transformation,” this was the week where enterprise leaders came together to ...